A

ArsenalBio

86 employees

ArsenalBio is a programmable cell therapy company that offers advanced CAR T-cell therapies for solid tumors.

Basic info

Industry

biotechnology

Sectors

Biotechnology
technology
cancer
Life Science
Cloud Computing
immunology
artificial intelligence
Medical
cell therapy
machine learning

Date founded

2019

Funding rounds raised

Total raised

$221M

from 13 investors over 13 rounds

A

ArsenalBio raised $221M on September 6, 2022

Investors: Parker Institute for Cancer Immunotherapy, Kleiner Perkins, SoftBank Investment Advisers, Hitachi Ventures, UCSF, Sixth Street and Westlake Village BioPartners®

A

ArsenalBio raised $85M on October 17, 2019

Investors: UCSF Foundation Investment Company, Parker Institute for Cancer Immunotherapy, Westlake Village BioPartners®, Osage University Partners (OUP), University of California and Kleiner Perkins

FAQ